Showing 8701-8710 of 18582 results for "".
- AI and Neuroprognosis: Transforming Critical Care with Machine Learninghttps://reachmd.com/news/ai-and-neuroprognosis-transforming-critical-care-with-machine-learning/2475396/AI and Neuroprognosis: Transforming Critical Care with Machine Learning Accurate early prognostication in traumatic spinal cord injuries remains challenging, limiting neurologists' ability to tailor interventions and i
- The Shifting Landscape of Primary Care: Hospital and Private Equity Affiliations Transforming Practicehttps://reachmd.com/news/the-shifting-landscape-of-primary-care-hospital-and-private-equity-affiliations-transforming-practice/2474852/In recent years, primary care has experienced a profound transformation as hospitals and private equity firms increasingly affiliate with providers, altering the financial and operational dynamics of healthcare delivery. Primary care i
- Andropause: Exploring Hormonal Changes in Aging Menhttps://reachmd.com/news/andropause-exploring-hormonal-changes-in-aging-men/2474732/Aging introduces significant endocrine shifts in men that are vital to understanding the male aging process. A pivotal finding is the gradual reduction in testosterone, akin to hormonal changes during menopause. Recognizing this shift i
- Decoding the Genetic and Epigenetic Landscape of Polycystic Ovary Syndromehttps://reachmd.com/news/gene-alterations-and-their-role-in-polycystic-ovary-syndrome/2474598/Polycystic ovary syndrome (PCOS) is a prevalent and complex endocrine disorder, impacting up to 20% of women of reproductive age worldwide. Recent advances in genomics and epigenetics are unraveling the intricate biological mechanisms behind its development. These i
- Genetic Predictive Modeling in Pancreatic Cancer: Refined Patient Selection for Surgeryhttps://reachmd.com/news/genetic-predictive-modeling-in-pancreatic-cancer-refined-patient-selection-for-surgery/2474364/An innovative Japanese predictive model utilizes genetic data with traditional tumor markers to improve survival predictions and optimize surgical decisions in advanced pancreatic cancer. Overview of the Predictive Model Breakthroughs i
- Medical Marijuana: Managing Cancer-related Symptomshttps://reachmd.com/news/medical-marijuana-managing-cancer-related-symptoms/2474275/A recent meta-analysis indicates that medical marijuana provides much-needed relief for cancer patients by alleviating symptoms such as pain, appetite loss, and nausea. However, the Schedule I classification of cannabis has historically hindered comprehensive resear
- Secukinumab Reduces Erosions in Psoriatic Arthritis Patientshttps://reachmd.com/news/secukinumab-reduces-erosions-in-psoriatic-arthritis-patients/2471713/Secukinumab significantly reduced erosion progression in patients with psoriatic arthritis (PsA), according to findings from a phase 4 randomized, double-blind, placebo-controlled trial. The study evaluated the impact of the I
- Understanding the New Dynamics of Antibody Responses in HIV Vaccinationhttps://reachmd.com/news/understanding-the-new-dynamics-of-antibody-responses-in-hiv-vaccination/2470976/What's New Recent research from Scripps Research Institute has uncovered unexpected antibody behaviors in response to HIV vaccines, offering insights that could lead to enhanced vaccine strategies. Significance This discovery is significant because i
- Blood Pressure Variability and Glaucoma: A Link to Visual Field Loss Progressionhttps://reachmd.com/news/blood-pressure-variability-and-glaucoma-a-link-to-visual-field-loss-progression/2470927/What's New This article discusses a study that examines how long-term variability in blood pressure affects visual field progression in glaucoma patients. Significance Understanding this relationship is crucial for managing glaucoma progression and i
- Finerenone reduces CV death or total HF events in patients with HFmrEF or HFpEFhttps://reachmd.com/news/finerenone-reduces-cv-death-or-total-hf-events-patients-hfmref-or-hfpef/2468010/This summary is based on the presentation of Scott Solomon, MD (Boston, MA, US) at the ESC Congress 2024 –Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction: FINEARTS-HF Introduction and methods Currently, the only class I